H1B Report
Side-by-side comparison

Novartis Institutes for BioMedical Research, Inc. vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricNovartis Institutes for BioMedical Research, Inc.WIPRO LIMITED
Total filings96472,392
Certified %96.37%91.61%
Denied %0.93%0.37%
Withdrawn %1.76%1.37%
Cert-withdrawn %0.93%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJNJ

Outcomes — Novartis Institutes for BioMedical Research, Inc.

DOL case-status mix.

Outcome breakdown: Certified 96.4%, Cert-withdrawn 0.9%, Withdrawn 1.8%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Novartis Institutes for BioMedical Research, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201065
FY201154
FY201264
FY201358
FY201480
FY201569
FY201676
FY201782
FY201862
FY201970
FY20204
FY20219
FY20226
FY202313
FY2024106
FY202592
FY202654
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Novartis Institutes for BioMedical Research, Inc.

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.